Tag: CBT > CBD FDA: Page 6

Compliance

Curaleaf Scrubs CBD Health Claims From Its Pages in Response to FDA Warning

Curaleaf “immediately began an extensive review of its website and social media platforms to remove all statements that FDA identified as non-compliant.”

July 29, 2019

Legislation and Regulation

FDA Issues Warning to Curaleaf for 'Unsubstantiated' CBD Health Claims

The warning letter included some examples of how Curaleaf Hemp products have been marketed on the company's social media accounts.

July 24, 2019

Finance

Read the Public Comments to the FDA on CBD Policy

The 2018 Farm Bill didn’t legalize CBD, per se; rather, the descheduling of hemp created a legal gray area for the cannabinoid, one which the FDA is working to clarify this year.

July 18, 2019

International

Cannabis Stocks Rally After FDA Says It Will Speed Up Effort to Create Rules for CBD

The FDA said it is expediting its effort to create a regulatory framework for CBD with plans to publish a report on its progress by early fall.

July 16, 2019